These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20186003)

  • 1. Comparison of colonoscopy and fecal occult blood testing as a first-line screening of colonic lesions in patients with newly diagnosed acromegaly.
    Bogazzi F; Lombardi M; Scattina I; Urbani C; Marciano E; Costa A; Pepe P; Rossi G; Martino E
    J Endocrinol Invest; 2010 Sep; 33(8):530-3. PubMed ID: 20186003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of acromegalic patients at risk of developing colonic adenomas.
    Bogazzi F; Cosci C; Sardella C; Costa A; Manetti L; Gasperi M; Rossi G; Bartalena L; Martino E
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1351-6. PubMed ID: 16449330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of colorectal lesions by using autofluorescence colonoscopy in acromegalics and their relation to serum growth hormone and insulin-like growth factor-1 levels.
    Matyja V; Kos-Kudla B; Foltyn W; Strzelczyk J; Latos W; Marek B; Kajdaniuk D; Karpe J; Ostrowska Z; Sieron-Stoltny K; Sieron A
    Neuro Endocrinol Lett; 2006 Oct; 27(5):639-43. PubMed ID: 17159821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the OC Sensor
    Vitellius C; Laly M; Banaszuk AS; Deherce I; Cornet N; Bertrais S; Saulnier P; Caroli-Bosc FX
    Eur J Epidemiol; 2019 Feb; 34(2):163-172. PubMed ID: 30536183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening.
    Liedenbaum MH; van Rijn AF; de Vries AH; Dekker HM; Thomeer M; van Marrewijk CJ; Hol L; Dijkgraaf MG; Fockens P; Bossuyt PM; Dekker E; Stoker J
    Gut; 2009 Sep; 58(9):1242-9. PubMed ID: 19625276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is barium enema an adequate diagnostic test for the evaluation of patients with positive fecal occult blood?
    Ramos C; De Jesús-Caraballo J; Toro DH; Ojeda A; Martínez-Souss J; Dueño MI; Cruz-Correa M
    Bol Asoc Med P R; 2009; 101(2):23-8. PubMed ID: 19954097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small adenomas detected during fecal occult blood test screening for colorectal cancer. The impact of serendipity.
    Ransohoff DF; Lang CA
    JAMA; 1990 Jul; 264(1):76-8. PubMed ID: 2192093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the performance of guaiac-based and two immunochemical fecal occult blood tests for identifying advanced colorectal neoplasia in Taiwan.
    Ou CH; Kuo FC; Hsu WH; Lu CY; Yu FJ; Kuo CH; Wang JY; Wu MT; Shiea J; Wu DC; Hu HM
    J Dig Dis; 2013 Sep; 14(9):474-83. PubMed ID: 23701988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
    Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
    Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel indicator for surveillance colonoscopy following colorectal cancer resection.
    Skaife P; Seow-Choen F; Eu KW; Tang CL
    Colorectal Dis; 2003 Jan; 5(1):45-8. PubMed ID: 12780926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon polyps and cancer.
    Kronborg O
    Endoscopy; 2002 Jan; 34(1):69-72. PubMed ID: 11778132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer).
    Stoffel EM; Turgeon DK; Stockwell DH; Zhao L; Normolle DP; Tuck MK; Bresalier RS; Marcon NE; Baron JA; Ruffin MT; Brenner DE; Syngal S;
    Cancer Prev Res (Phila); 2008 Nov; 1(6):470-5. PubMed ID: 19138994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of computed tomographic colonography for the screening of colorectal polyp in acromegalic patients: a prospective study.
    Ramos O; Boguszewski CL; Teixeira S; De Bem R; Parolim B; Prolla JC
    Arq Gastroenterol; 2009; 46(2):90-6. PubMed ID: 19578607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ; Liu Y; Kirby J; Vora P; Moayyedi P
    Trials; 2015 Jul; 16():296. PubMed ID: 26156248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE PREVALENCE OF COLONIC POLYPS IN PATIENTS WITH ACROMEGALY: A CASE-CONTROL, NESTED IN A COHORT COLONOSCOPIC STUDY.
    Gonzalez B; Vargas G; Mendoza V; Nava M; Rojas M; Mercado M
    Endocr Pract; 2017 May; 23(5):594-599. PubMed ID: 28225314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.